XML 25 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Operating activities:  
Net income (loss)$ 7,093$ (4,721)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:  
Depreciation and amortization21,4262,260
Share-based compensation1,9721,506
Amortization of deferred financing costs1,135175
Amortization of ground lease164 
Equity in earnings from unconsolidated entities(2,169) 
Deferred income tax benefit 23
Other142 
Changes in assets and liabilities:  
Restricted cash, net(686) 
Hotel receivables(10,024)(3,453)
Prepaid expenses and other assets(5,024)(2,345)
Accounts payable and accrued expenses13,3597,941
Advance deposits1,035357
Net cash provided by operating activities28,4231,743
Investing activities:  
Acquisition of hotel properties(467,135)(331,650)
Improvements and additions to hotel properties(26,348)(350)
Contributions to unconsolidated entities(165,434) 
Deposit on hotel property (1,000)
Redemption of certificates of deposits 70,000
Purchase of corporate office equipment, computer software, and furniture(145)(464)
Restricted cash, net(3,559)(1,061)
Net cash used in investing activities(662,621)(264,525)
Financing activities:  
Gross proceeds from issuance of common shares235,980332,350
Gross proceeds from issuance of preferred shares225,150 
Payment of offering costs - common and preferred shares(17,108)(15,392)
Payment of deferred financing costs(2,031)(2,300)
Contributions from non-controlling interest95 
Borrowings under senior credit facility42,000 
Repayments under senior credit facility(42,000) 
Proceeds from mortgage debt67,000 
Repayments of mortgage debt(736) 
Repurchase of shares(140) 
Distributions - common shares/units(16,025) 
Distributions - preferred shares(3,391) 
Net cash provided by financing activities488,794314,658
Net change in cash and cash equivalents(145,404)51,876
Cash and cash equivalents, beginning of year220,722319,119
Cash and cash equivalents, end of period$ 75,318$ 370,995